Document is current
Any future updates will be listed below
-
Authors
Kappelman, Michael D. https://orcid.org/0000-0002-0469-6856
Lewis, J. D.
Zhang, X.
Lin, F. C.
Weisbein, L.
Chen, W.
Burris, J.
Dorand, J. E.
Parlett, L. E.
Haynes, K.
Nair, V.
Kaul, A. F.
Dobes, A.
Long, M. D.
-
Funding
Funding for this research was provided by:
Patient-Centered Outcomes Research Institute
- License Information
-
More Information
Article History
Received: 7 November 2022
Accepted: 30 March 2023
First Online: 28 April 2023
Declarations
:
: MDK has consulted for Abbvie, Janssen, Pfizer, Takeda, and Lilly, is a shareholder in Johnson & Johnson, and has received research support from Pfizer, Takeda, Janssen, AbbVie, Lilly, Genentech, Boehringer Ingelheim, Bristol Myers Squibb, Celtrion, and Arenapharm. JDL has served as a consultant for Janssen Pharmaceuticals, Samsung Bioepis, Bristol-Myers Squibb, Merck, Celgene, AbbVie, Entasis Therapeutics, and Bridge Biotherapeutics. JDL has served as a paid member of a data-monitoring committee for Pfizer, UCB, Gilead, Arena Pharmaceuticals, Protagonist Therapeutics, and Amgen. JDL has received research funding from Janssen Pharmaceuticals, AbbVie, and Takeda Pharmaceuticals. JDL has received educational grant funding from Takeda Pharmaceuticals. XZ, FL, LW, WC, JB, VN, AK, AD report no conflicts of interest. JD is a shareholder in Pfizer. LP is employed by HealthCore/Anthem. KH was employed by Anthem at the time of the research and is currently an employee of Janssen Research & Development. ML consulting for AbbVie, Janssen, Pfizer, Takeda, Lilly, BMS, Prometheus, Target Pharmasolutions, Calibr, Roche, Genentech, Theravance, Research support Takeda, Pfizer.
